CHFS Surveillance COVID-19 Testing for Long-Term Care Facilities FAQs

CHFS Surveillance COVID-19 Testing for Long-Term Care Facilities FAQs

FAQs Updated as of June 28, 2022, and salient points follow:

Beginning July 1, 2022, CHFS-contracting clinical labs will provide the following:

  1. Antigen Test Kits for ongoing surveillance test administration by the provider, and
  2. PCR testing to detect the presence of COVID-19 infections for
    • Any eligible person with a positive antigen test result, or
    • Any eligible person with a physician's order for a PCR test (following CDC-approved guidance).


To see an updated list of participating laboratories, Click Here and scroll down to the bottom left-hand side of the page to "List of participating labs: Beginning July 1, 2022." These clinical laboratories are eligible for reimbursement by CHFS until the federal funding for this program expires. There is no charge to residents for these tests.


Note to KSLA Associate Members - current clinical laboratories who desire to participate are invited to submit applications for consideration to CHFS.


Providers will continue reporting positive results only to KHIE or NHSN, the tested individual, and the selected participating clinical lab in the same fashion as for the first half of 2022.


This program is not mandatory for assisted living facilities or personal care homes, but is available, voluntary and strongly encouraged.


For additional information about the testing program, contact Carrie Anglin, or 502-385-1712.

Gain all the benefits KSLA has to offer

Join Now